NCT02040155View on ClinicalTrials.gov

Real Time In-Vivo Dosimetry For Gynecologic Brachytherapy

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Cancer of the Cervix, Cancer of the Endometrium
Interventions
DEVICE

Novel nano-scintillator fiber-optic dosimeter (nanoFOD)

This is an observational study whose purpose is to determine the feasibility of using a novel nano-scintillator fiber-optic dosimeter (nanoFOD) for the real time dosimetric monitoring of brachytherapy treatment.

Trial Locations (1)

27710

Duke Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

Wallace H. Coulter Foundation

OTHER

lead

Duke University

OTHER